• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-454-3p 通过靶向 TGFB2 抑制非小细胞肺癌细胞的增殖和转移。

miR‑454‑3p inhibits non‑small cell lung cancer cell proliferation and metastasis by targeting TGFB2.

机构信息

Department of Thoracic Surgery, The Yuebei People's Hospital of Shaoguan, Shaoguan, Guangdong 512025, P.R. China.

Department of Nursing, Medical College of Shaoguan University, Shaoguan, Guangdong 512026, P.R. China.

出版信息

Oncol Rep. 2021 May;45(5). doi: 10.3892/or.2021.8018. Epub 2021 Mar 24.

DOI:10.3892/or.2021.8018
PMID:33760169
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8020204/
Abstract

Accumulating studies have suggested that microRNAs (miRs) play a significant role in lung cancer development and progression, especially in non‑small cell lung cancer (NSCLC). The present study aimed to investigate the associations between miR‑454‑3p and NSCLC progression. qPCR assay was applied to examine the expression of miR‑454‑3p and transforming growth factor‑β2 (TGFB2) in tissues and cell lines. CCK‑8 and EdU assays were used to detect cell proliferation. Wound‑healing and Transwell assays were conducted to assess cell migration and invasion. Western blotting assay was performed to explore the protein levels of epithelial‑mesenchymal transition (EMT) markers. The interaction between miR‑454‑3p and TGFB2 was investigated with a luciferase reporter assay. miR‑454‑3p was downregulated in NSCLC tissues and NSCLC cell lines. miR‑454‑3p overexpression led to the suppression of proliferation, migration, and invasion in A549 and NCI‑H1650 cells. In addition, the overexpression of miR‑454‑3p in A549 and NCI‑H1650 cells significantly inhibited EMT. TGFB2 was revealed to be a direct target of miR‑454‑3p by using TargetScan database and luciferase reporter assay. TGFB2 was observed to be upregulated in NSCLC tissues and cell lines. Further mechanistic studies revealed that the inhibitory effects of miR‑454‑3p on NSCLC were reversed upon overexpression of TGFB2. These findings provided strong evidence that miR‑454‑3p suppressed NSCLC cell proliferation and metastasis by targeting TGFB2. The study suggests that targeting miR‑454‑3p could be a promising strategy for treating NSCLC.

摘要

越来越多的研究表明,微小 RNA(miRs)在肺癌的发生和发展中发挥着重要作用,尤其是在非小细胞肺癌(NSCLC)中。本研究旨在探讨 miR-454-3p 与 NSCLC 进展之间的关系。qPCR 检测用于检测组织和细胞系中 miR-454-3p 和转化生长因子-β2(TGFB2)的表达。CCK-8 和 EdU 检测用于检测细胞增殖。划痕愈合和 Transwell 检测用于评估细胞迁移和侵袭。Western blot 检测用于探索上皮间质转化(EMT)标志物的蛋白水平。通过荧光素酶报告基因检测研究 miR-454-3p 和 TGFB2 之间的相互作用。miR-454-3p 在 NSCLC 组织和 NSCLC 细胞系中下调。miR-454-3p 过表达导致 A549 和 NCI-H1650 细胞增殖、迁移和侵袭受到抑制。此外,miR-454-3p 在 A549 和 NCI-H1650 细胞中的过表达显著抑制 EMT。使用 TargetScan 数据库和荧光素酶报告基因检测证实 TGFB2 是 miR-454-3p 的直接靶标。TGFB2 在 NSCLC 组织和细胞系中上调。进一步的机制研究表明,miR-454-3p 对 NSCLC 的抑制作用在 TGFB2 过表达时被逆转。这些发现为 miR-454-3p 通过靶向 TGFB2 抑制 NSCLC 细胞增殖和转移提供了有力证据。研究表明,靶向 miR-454-3p 可能是治疗 NSCLC 的一种有前途的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e6/8020204/a0cc559fa2f4/or-45-05-8018-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e6/8020204/a103431cb14c/or-45-05-8018-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e6/8020204/a0cc559fa2f4/or-45-05-8018-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e6/8020204/a103431cb14c/or-45-05-8018-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e6/8020204/a0cc559fa2f4/or-45-05-8018-g05.jpg

相似文献

1
miR‑454‑3p inhibits non‑small cell lung cancer cell proliferation and metastasis by targeting TGFB2.miR-454-3p 通过靶向 TGFB2 抑制非小细胞肺癌细胞的增殖和转移。
Oncol Rep. 2021 May;45(5). doi: 10.3892/or.2021.8018. Epub 2021 Mar 24.
2
miR-200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non-small cell lung cancer cells.miR-200b/c 靶向调节 RhoE 的表达,抑制非小细胞肺癌细胞的增殖和侵袭。
Int J Oncol. 2018 Oct;53(4):1732-1742. doi: 10.3892/ijo.2018.4493. Epub 2018 Jul 20.
3
UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.UBE2C 被 miR-548e-5p 直接靶向,增加了与非小细胞肺癌中 EMT 标志物蛋白锌指 E-box 结合同源框 1/2 相互作用的癌细胞的细胞生长和侵袭能力。
Theranostics. 2019 Mar 17;9(7):2036-2055. doi: 10.7150/thno.32738. eCollection 2019.
4
Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.Sirtuin 7 通过促进 G1/S 期和上皮-间充质转化以及激活 AKT 和 ERK1/2 信号通路促进非小细胞肺癌的进展。
Oncol Rep. 2020 Sep;44(3):959-972. doi: 10.3892/or.2020.7672. Epub 2020 Jul 7.
5
Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.长链非编码 RNA PRNCR1 通过 PRNCR1/miR-126-5p/MTDH 轴调节非小细胞肺癌细胞的增殖、凋亡、迁移、侵袭和 EMT。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20193153.
6
MicroRNA-16 inhibits the proliferation, migration and invasion of non-small cell lung carcinoma cells by down-regulating matrix metalloproteinase-19 expression.MicroRNA-16 通过下调基质金属蛋白酶-19 的表达抑制非小细胞肺癌细胞的增殖、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5260-5269. doi: 10.26355/eurrev_201906_18192.
7
Hsa_circ_0016760 exacerbates the malignant development of non‑small cell lung cancer by sponging miR‑145‑5p/FGF5.Hsa_circ_0016760 通过海绵吸附 miR-145-5p/FGF5 来加剧非小细胞肺癌的恶性发展。
Oncol Rep. 2021 Feb;45(2):501-512. doi: 10.3892/or.2020.7899. Epub 2020 Dec 14.
8
MicroRNA-373 Inhibits Cell Proliferation and Invasion via Targeting BRF2 in Human Non-small Cell Lung Cancer A549 Cell Line.微小 RNA-373 通过靶向人非小细胞肺癌 A549 细胞系中的 BRF2 抑制细胞增殖和侵袭。
Cancer Res Treat. 2018 Jul;50(3):936-949. doi: 10.4143/crt.2017.302. Epub 2017 Oct 12.
9
Neuropilin 1 modulates TGF‑β1‑induced epithelial‑mesenchymal transition in non‑small cell lung cancer.神经纤毛蛋白 1 调节转化生长因子-β1 诱导的非小细胞肺癌上皮-间质转化。
Int J Oncol. 2020 Feb;56(2):531-543. doi: 10.3892/ijo.2019.4938. Epub 2019 Dec 11.
10
MiR-206 may suppress non-small lung cancer metastasis by targeting CORO1C.miR-206 可能通过靶向 CORO1C 来抑制非小细胞肺癌转移。
Cell Mol Biol Lett. 2020 Mar 17;25:22. doi: 10.1186/s11658-020-00216-x. eCollection 2020.

引用本文的文献

1
The MicroRNA miR-454 and the mediator complex component MED12 are regulators of the androgen receptor pathway in prostate cancer.微小RNA miR-454和中介体复合物成分MED12是前列腺癌雄激素受体途径的调节因子。
Sci Rep. 2025 Mar 25;15(1):10272. doi: 10.1038/s41598-025-95250-0.
2
STK33 as the functional substrate of miR-454-3p for suppression and apoptosis in neuroblastoma.STK33作为miR-454-3p在神经母细胞瘤中发挥抑制和凋亡作用的功能性底物。
Mol Cells. 2024 Dec;47(12):100145. doi: 10.1016/j.mocell.2024.100145. Epub 2024 Nov 6.
3
MiR-454-3p regulates high glucose-induced mesothelial-mesenchymal transition and glycolysis in peritoneal mesothelial cells by targeting STAT3.

本文引用的文献

1
The multifaceted roles of microRNAs in differentiation.microRNAs 在分化中的多效性作用。
Curr Opin Cell Biol. 2020 Dec;67:118-140. doi: 10.1016/j.ceb.2020.08.015. Epub 2020 Nov 3.
2
Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity.原发性肺癌和远处转移灶的多组学分析揭示,免疫抑制是具有转移可塑性的肿瘤细胞的共同特征。
Genome Biol. 2020 Nov 4;21(1):271. doi: 10.1186/s13059-020-02175-0.
3
MicroRNA-454-3p inhibits cell proliferation and invasion in esophageal cancer by targeting insulin-like growth factor 2 mRNA-binding protein 1.
miR-454-3p 通过靶向 STAT3 调节高糖诱导的腹膜间皮细胞间充质转化和糖酵解。
Ren Fail. 2024 Dec;46(2):2394635. doi: 10.1080/0886022X.2024.2394635. Epub 2024 Aug 27.
4
MiRNAs and Microbiota in Non-Small Cell Lung Cancer (NSCLC): Implications in Pathogenesis and Potential Role in Predicting Response to ICI Treatment.miRNAs 与非小细胞肺癌(NSCLC)中的微生物群:在发病机制中的意义及在预测 ICI 治疗反应中的潜在作用。
Int J Mol Sci. 2024 Jun 18;25(12):6685. doi: 10.3390/ijms25126685.
5
Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer.微小RNA对非小细胞肺癌的调控作用及治疗潜力
Heliyon. 2023 Nov 14;9(11):e22080. doi: 10.1016/j.heliyon.2023.e22080. eCollection 2023 Nov.
6
The lncRNA HOTAIR: a pleiotropic regulator of epithelial cell plasticity.长链非编码 RNA HOTAIR:上皮细胞可塑性的多效调节因子。
J Exp Clin Cancer Res. 2023 Jun 13;42(1):147. doi: 10.1186/s13046-023-02725-x.
7
TGF-β as Predictive Marker and Pharmacological Target in Lung Cancer Approach.转化生长因子-β作为肺癌治疗中的预测标志物和药理学靶点
Cancers (Basel). 2023 Apr 14;15(8):2295. doi: 10.3390/cancers15082295.
8
Non-Coding RNAs as Biomarkers for Embryo Quality and Pregnancy Outcomes: A Systematic Review and Meta-Analysis.非编码 RNA 作为胚胎质量和妊娠结局的生物标志物:系统评价和荟萃分析。
Int J Mol Sci. 2023 Mar 17;24(6):5751. doi: 10.3390/ijms24065751.
9
Identification of hub genes related to CD4 memory T cell infiltration with gene co-expression network predicts prognosis and immunotherapy effect in colon adenocarcinoma.通过基因共表达网络鉴定与CD4记忆性T细胞浸润相关的枢纽基因预测结肠腺癌的预后和免疫治疗效果
Front Genet. 2022 Aug 29;13:915282. doi: 10.3389/fgene.2022.915282. eCollection 2022.
10
MicroRNAs as Potential Biomarkers in the Differential Diagnosis of Lipomatous Tumors and Their Mimics.微小 RNA 作为脂肪性肿瘤及其类似物鉴别诊断的潜在生物标志物。
Int J Mol Sci. 2022 Jul 15;23(14):7804. doi: 10.3390/ijms23147804.
微小RNA-454-3p通过靶向胰岛素样生长因子2信使核糖核酸结合蛋白1抑制食管癌细胞的增殖和侵袭。
Oncol Lett. 2020 Dec;20(6):359. doi: 10.3892/ol.2020.12223. Epub 2020 Oct 14.
4
Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury.调控微小 RNA 功能治疗癌症或器官损伤的策略。
Pharmacol Rev. 2020 Jul;72(3):639-667. doi: 10.1124/pr.119.019026.
5
miR-410 induces both epithelial-mesenchymal transition and radioresistance through activation of the PI3K/mTOR pathway in non-small cell lung cancer.miR-410 通过激活非小细胞肺癌中的 PI3K/mTOR 通路诱导上皮-间充质转化和放射抵抗。
Signal Transduct Target Ther. 2020 Jun 12;5(1):85. doi: 10.1038/s41392-020-0182-2.
6
TGFB2 serves as a link between epithelial-mesenchymal transition and tumor mutation burden in gastric cancer.TGFB2 在胃癌中作为上皮-间充质转化和肿瘤突变负担之间的联系。
Int Immunopharmacol. 2020 Jul;84:106532. doi: 10.1016/j.intimp.2020.106532. Epub 2020 May 6.
7
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
8
miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression.miR-324-5p 通过下调转化生长因子β2 的表达抑制胆囊癌细胞的转移行为。
Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):315-324. doi: 10.1080/21691401.2019.1703724.
9
Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy.肺癌靶向治疗中肿瘤异质性和耐药机制的新见解。
J Hematol Oncol. 2019 Dec 9;12(1):134. doi: 10.1186/s13045-019-0818-2.
10
Beyond Palliation: The Rationale for Metastasis-Directed Therapy for Metastatic Non-Small Cell Lung Cancer.超越姑息治疗:转移性非小细胞肺癌转移导向治疗的理论依据
J Thorac Oncol. 2019 Sep;14(9):1510-1512. doi: 10.1016/j.jtho.2019.05.025. Epub 2019 Jul 2.